Journal of Pharmacological Sciences (Jul 2020)

Finding a resveratrol analogue as potential anticancer agent with apoptosis and cycle arrest

  • Zhen-Hui Xin,
  • Hui-Hui Yang,
  • Yu-Han Gan,
  • Ya-Li Meng,
  • Ya-Peng Li,
  • Li-Ping Ge,
  • Cun-Hui Zhang,
  • Lian-Na Liu,
  • Yan-Fei Kang

Journal volume & issue
Vol. 143, no. 3
pp. 238 – 241

Abstract

Read online

Resveratrol has been extensively studied as the anti-cancer agent. A variety of resveratrol analogues have been developed with structural modification to improve its bioactivity. In this work, resveratrol analogues, compound 1-4, were designed and synthesized with the Stille–Heck reaction. These results showed compound 1–4 had better anticancer effect than that of parent resveratrol. Especially compound 1 ((E)-4,4′-(ethene-1,2-diyl)bis(3-methylphenol)) displayed the excellent cytotoxicity and high selectivity. The mechanism research indicated compound 1 inhibited cell proliferation by binary paths of cell cycle arrest in S phase regulated by cyclin A1/A2 and apoptosis induction mediated by Bax/Bcl2 in a prooxidant manner.

Keywords